- Home
- GSK vs HCA Comparison
GSK vs HCA Comparison
Compare GSK & HCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSK
- HCA
- Stock Information
- Founded
- GSK 1715
- HCA 1968
- Country
- GSK United Kingdom
- HCA United States
- Employees
- GSK N/A
- HCA N/A
- Industry
- GSK Biotechnology: Pharmaceutical Preparations
- HCA Hospital/Nursing Management
- Sector
- GSK Health Care
- HCA Health Care
- Exchange
- GSK Nasdaq
- HCA Nasdaq
- Market Cap
- GSK 86.1B
- HCA 78.2B
- IPO Year
- GSK N/A
- HCA N/A
- Fundamental
- Price
- GSK $38.04
- HCA $377.38
- Analyst Decision
- GSK Hold
- HCA Buy
- Analyst Count
- GSK 3
- HCA 16
- Target Price
- GSK N/A
- HCA $390.93
- AVG Volume (30 Days)
- GSK 4.9M
- HCA 1.3M
- Earning Date
- GSK 07-30-2025
- HCA 07-22-2025
- Dividend Yield
- GSK 4.23%
- HCA 0.77%
- EPS Growth
- GSK N/A
- HCA 12.23
- EPS
- GSK 0.98
- HCA 22.47
- Revenue
- GSK $40,735,668,430.00
- HCA $71,585,000,000.00
- Revenue This Year
- GSK $6.70
- HCA $6.88
- Revenue Next Year
- GSK $5.42
- HCA $5.16
- P/E Ratio
- GSK $18.78
- HCA $16.68
- Revenue Growth
- GSK 2.57
- HCA 7.30
- 52 Week Low
- GSK $31.72
- HCA $289.98
- 52 Week High
- GSK $44.67
- HCA $417.14
- Technical
- Relative Strength Index (RSI)
- GSK 40.16
- HCA 56.61
- Support Level
- GSK $40.67
- HCA $350.74
- Resistance Level
- GSK $42.63
- HCA $380.56
- Average True Range (ATR)
- GSK 0.66
- HCA 9.41
- MACD
- GSK -0.41
- HCA -1.41
- Stochastic Oscillator
- GSK 4.67
- HCA 74.37
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.
About HCA HCA Healthcare Inc.
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of December 2024, the firm owned and operated 190 hospitals, 124 freestanding outpatient surgery centers, and a broad network of physician offices, urgent-care clinics, and freestanding emergency rooms across 20 states and a small foothold in England.